• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Cerebral Astrocytoma, Childhood

Cerebral Astrocytoma, Childhood - 3 Studies Found

Terminated : Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma
: Brain and Central Nervous System Tumors
: 2002-09-06
:
  • Drug: O6-benzylguanine
  • Drug: polifeprosan

Active, not recruiting : Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
:
  • Childhood Cerebellar Anaplastic Astrocytoma
  • Childhood Cerebral Anaplastic Astrocytoma
  • <
    : 2010-11-05
    :
    • Biological: Bevacizumab Given

Terminated : Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
: Brain and Central Nervous System Tumors
: 1999-11-01
:
  • Drug: antineoplaston A10
  • Drug: antineoplas

Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.